• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITHS MEDICAL ASD, INC CLEO® 90 INFUSION SET; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITHS MEDICAL ASD, INC CLEO® 90 INFUSION SET; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Catalog Number 21-7220-24
Device Problem Kinked (1339)
Patient Problems Hyperglycemia (1905); Diabetic Ketoacidosis (2364)
Event Type  Injury  
Manufacturer Narrative
Customer has not yet returned the device to the manufacturer for device evaluation.When and if the device becomes available and is returned and evaluated the manufacturer will file a follow-up report detailing the results of the evaluation.Actual date unknown.Events were reported to have happened between (b)(6) 2016.Possible lot numbers 76x054 or 76x143.Expiration dates: (lot 76x054) march 28, 2021 and (lot 76x143) august 28, 2021.Manufacturing dates: (lot 76x054) march 29, 2016 and (lot 76x143) august 30, 2016.
 
Event Description
It was reported that the patient had adverse events for two weeks due to cleo® 90 infusion sets along with a t-slim insulin pump.The patient had their first cleo infusion set changed due to high blood glucose around 350mg/dl in which the blood sugar didn't come down.The patient went to the emergency room and subsequently the hospital for 3 days after the second infusion set didn't work as intended and blood sugars rose to 529mg/dl.The patient met with a diabetic educator who found that the second site was kinked the patient was diagnosed with diabetic ketoacidosis in the large range.The patient went home and her blood sugar spiked for the third time around 550mg/dl.The patient started shots immediately which brought her blood sugar down with only moderate ketones.The patient didn't go to the hospital at that time.The outcomes of the events were resolved.No additional information at this time.See mfr number for related events: 3012307300-2017-00294, 3012307300-2017-00296.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CLEO® 90 INFUSION SET
Type of Device
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
SMITHS MEDICAL ASD, INC
6000 nathan lane north
minneapolis MN 55442
Manufacturer (Section G)
SMITHS HEALTHCARE MFG
s.a de c.v. ave
calidad no. 4,
tijuana, b.c. 22425
MX   22425
Manufacturer Contact
lisa perz
6000 nathan lane north
minneapolis, MN 55442
7633833074
MDR Report Key6304313
MDR Text Key66615347
Report Number3012307300-2017-00295
Device Sequence Number1
Product Code FPA
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K042172
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Reporter Occupation Patient
Type of Report Initial
Report Date 01/10/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/06/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Catalogue Number21-7220-24
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received01/10/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-